希望这本对生信友好的3分+的期刊不会被踢出SCI

Artificial Cells Nanomedicine and Biotechnology是一本对生信友好的期刊，影响因子(2019):3.434，中科院最新分区：3区， Impact Factor Best Quartile（2019）：Q2，CiteScore（2019）：5，Source Normalized Impact per Pape（2019）：0.764，Scimago Journal Rank（2019）：0.577，版面费：$2,500。

期刊收录的研究领取：

Artificial cells:

synthetic biology, synthetic organelles, build-a-cell

artificial exosomes/extracellular vesicles

synthetic genomics, self-assembly, origins of life

application of artificial cells as:

- biotherapeutics and immunotherapeutic (including stem cell therapy)

- blood substitutes oxygen therapeutics

- novel carriers for therapeutics (e.g. vaccines, drugs)

bio-immunosorbents therapy

Nanomedicine and biotechnology:

bio/molecular nanosystems, nanoparticles including nanoscale bio/therapeutics and nano drug carriers, extracellular vesicles, smart and stimuli responsive nanobiosystems

human physiology mimicking models, aka organ-on-chip

nanotoxicity, nanotoxicology, biomedical sensors including sensor fusion

mechanobiology, mechanopharmacology, mechanomedicine, precision nanomedicine

nanofabrication, nanolithography and nanopatterning for biomedical applications

single particle and single cell analysis, biomedical imaging, nanobiotechnology

The convergence of information science, nano-scale science and molecular biology - nano-bio-info-cogno:

bioconvergance and nano-bio-info-cogno network

integrated nano-bio-technology platforms including bioinformatics, cognition and prediction

这本期刊最主要的缺点就是被列入了中科院发布的《国际期刊预警名单（试行）》名单，而且预警等级：高，主要是自引率太高了，2019-2020自引率高达6.4%，相当于是江湖四大神~PLoS One的两倍（3.3%）。这自引率实在是有点恐怖，难怪会被列入预警名单高风险区域。想当年江湖四大神刊老大哥~Oncotarget就是因为自引率太高被踢出SCI了，Artificial Cells Nanomedicine and Biotechnology会不会遭遇跟它一样的命运呢？这个机会是非常大的，但是也不是绝对的。关于发表这本期刊的文章是否会被认可?这个需要结合自己单位进行分析，不同单位的政策是不一样的。